Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.74 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.57 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.55 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.55 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.54 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.54 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CETP | P11597 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL594176 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL308645 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL16389868 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL15281949 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL10600706 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL875221 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL8627798 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL308262 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL8623658 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL240206 | 1.00 | FAAH (0.74) | FAAHMEN1KMT2AMAPK1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8350080-B2 | Method for the production of acyl glycinates by means of direct oxidation | CLARIANT FINANCE (BVI) LIMITED (BV) | 2013-01-08 | — | — | US | claimed |
| EP-2061737-B1 | PROCESS FOR PREPARING ACYLGLYCINATES BY MEANS OF DIRECT OXIDATION | CLARIANT FINANCE BVI LTD (VG) | 2012-10-10 | — | — | EP | claimed |
| US-8093414-B2 | Process for preparing acylglycinates by means of direct oxidation | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-01-10 | — | — | US | claimed |
| EP-2250147-B1 | METHOD FOR THE PRODUCTION OF ACYL GYLCINATES BY MEANS OF DIRECT OXIDATION | CLARIANT FINANCE BVI LTD (VG) | 2011-10-12 | — | — | EP | claimed |
| US-20100305358-A1 | Method For The Production Of Acyl Glycinates By Means Of Direct Oxidation | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-12-02 | — | — | US | claimed |
| US-20100286418-A1 | Process For Preparing Acylglycinates By Means Of Direct Oxidation | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-11-11 | — | — | US | claimed |
| US-4039562-A | MALEIC ANHYDRIDE, FATTY ALCOHOL, ALKALI METAL SULFITE | REWO CHEMISCHE WERKE G.M.B.H. (DT) | 1977-08-02 | — | — | US | claimed |
| JP-62234010-A | — | — | None | — | — | JP | disclosed |
| JP-58052210-A | — | — | None | — | — | JP | disclosed |
| CN-107848937-B | Method for oxidizing alcohols using an oxygen-containing gas | 罗地亚经营管理公司 | 2024-03-29 | — | — | CN | disclosed |
| EP-3538059-B1 | ALUMINUM-FREE ANTIPERSPIRANT/DEODORANT COMPOSITIONS | COLGATE PALMOLIVE CO (US) | 2021-03-03 | — | — | EP | disclosed |
| EP-3534871-B1 | ALUMINUM-FREE ANTIPERSPIRANT/DEODORANT COMPOSITIONS | COLGATE PALMOLIVE CO (US) | 2021-03-03 | — | — | EP | disclosed |
| CN-111356755-A | Fuel-efficient passenger car lubricating oil composition | 雪佛龙日本有限公司 | 2020-06-30 | — | — | CN | disclosed |
| US-6436920-B1 | AN ANTIWRINKLE AND ANTIAGING AGENT (COSMETIC SKIN CARE AGENT) COMPRISING A GUANIDINE DERIVATIVE | KAO CORPORATION (JP) | 2002-08-20 | — | — | US | disclosed |
| US-6306848-B1 | SKIN TREATMENT | KAO CORPORATION (JP) | 2001-10-23 | — | — | US | disclosed |
| US-5827626-A | FORMING A FILM OF COLORED IMAGE FORMING MATERIAL COMPRISING A COPOLYMER OF STYRENE OR DERIVATIVE AND MONO OR DIESTER OF MALEIC ACID, PIGMENTS, PHOTOPOLYMERIZABLE UNSATURATED MONOMER, PHOTOINITIATOR; PHOTOCURING AND DEVELOPING | HITACHI CHEMICAL CO., LTD. (JP) | 1998-10-27 | — | — | US | disclosed |
| WO-1997035557-A1 | EXTERNAL SKIN-CARE COMPOSITION | KAO CORPORATION (JP) | 1997-10-02 | — | — | WO | disclosed |
| JP-S62234010-A | COMPOSITION FOR ORAL CAVITY APPLICATION | LION CORP | 1987-10-14 | — | — | JP | disclosed |
| JP-S5852210-A | COMPOSITION FOR ORAL CAVITY | LION CORP | 1983-03-28 | — | — | JP | disclosed |
| US-4039562-A | MALEIC ANHYDRIDE, FATTY ALCOHOL, ALKALI METAL SULFITE | REWO CHEMISCHE WERKE G.M.B.H. (DT) | 1977-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286418-A1 | Process For Preparing Acylglycinates By Means Of Direct Oxidation | FADS1, UGCG, AGPAT2 | FAAH 113/4885MEN1 2289/4885KMT2A 1479/4885 |
| US-20100305358-A1 | Method For The Production Of Acyl Glycinates By Means Of Direct Oxidation | ACOX1, ACOX3, ACADM | FAAH 443/4885MEN1 2255/4885KMT2A 1493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.